SOLASTA® Bio Expands Patent Portfolio and Reports Strong Global Field Trial Results
SOLASTA® Bio now holds 14 granted patents for its peptide-based bioinsecticides, including eight in the U.S. and six in Europe.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed
